Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 43.5414.3510.2811.5519.03

What is the latest EV/Core EBITDA ratio of VAISHALI PHARMA ?

The latest EV/Core EBITDA ratio of VAISHALI PHARMA is 43.54 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202443.54
Mar202314.35
Mar202210.28
Mar202111.55
Mar202019.03

How is EV/Core EBITDA of VAISHALI PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 43.54
203.41
Mar2023 14.35
39.59
Mar2022 10.28
-11.00
Mar2021 11.55
-39.31
Mar2020 19.03 -

Other Financial Ratios of VAISHALI PHARMA


Compare EV/Core EBITDA ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹130.5 Cr -2% -11% -44.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr -1.4% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹180,488.0 Cr 4.4% 15.9% 15.6% Stock Analytics
CIPLA ₹121,452.0 Cr -4.9% -0.8% 6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,057.0 Cr -0.6% 1.8% 15.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,220.0 Cr -4.1% -3.8% -4.3% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-2%

-11%

-44.7%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses